Former U.S. Assistant Surgeon General to Join MusclePharm (MSLP.OB) as Chief Scientific Director

QualityStocks would like to highlight MusclePharm Corporation. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes.

In the company’s news yesterday,

Muscle Pharm Corp. announced former Assistant Surgeon General Dr. Roscoe M. Moore, Jr. as its new chief scientific director.

Cory Gregory, president of MusclePharm, said Dr. Moore’s position will support the company’s progress toward its current and future objectives and operations.

“We are honored and excited that Dr. Roscoe M. Moore, Jr. is joining our company as chief scientific director. His experience and knowledge in the medical field and his background within the FDA and US Public Health Services will be a tremendous asset to MusclePharm. In addition to overseeing our next generation of product offerings, he will assist in our path toward insurance reimbursement for our Re-Con product for HIV patients suffering from involuntary weight loss and catabolic cachexia, which is a very large market,” Gregory stated in the press release. “Dr. Moore’s decision to join MusclePharm is a reinforcement of the quality and effectiveness of our products and our strong research and developments efforts.”

MusclePharm last month presented information of its Re-Con product to more than 200 attendees at the XVIII International Aids Conference in Vienna, Austria, sponsored by NAPWA and The AIDS Institute. Re-Con has demonstrated clinical attributes to fight the involuntary weight loss and catabolic cachexia associated with HIV patients on highly active antiretroviral therapy (HAART).

Dr. Moore noted the concern and risks of involuntary weight loss in patients with HIV, and said his position with MusclePharm will give him the opportunity to actively address those concerns.

“Unintentional and involuntary weight loss in people living with HIV/AIDS have long been recognized as a serious consequence of this disease. The nutritional requirements among persons undergoing antiretroviral therapy have not been adequately and systematically addressed. Therapeutic nutritional supplementation products, like those provided by MusclePharm, are essential in maintaining the health status of HIV/AIDS patients. I look forward to joining MusclePharm in order to provide the most effective evidence-based approach to assure appropriate and adequate therapeutic nutritional supplementation to mitigate the impact and progression of wasting syndrome in HIV/AIDS patients,” Dr. Moore stated.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.